Das Drug Centre Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 12.73 Cr
- Company Age 1 Year 3 Months
- Last Filing with ROC 31 Mar 2024
About Das Drug Centre
Das Drug Centre Private Limited (DDCPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 October 2023 (One year and three months 6 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 12.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Das Drug Centre Private Limited India is Nisha Agarwala as COMPANY SECRETARY. Piyasha Das, Pintu Das, and Baisakhi Das serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U75000WB2023PTC265873
-
Company No.
265873
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Oct 2023
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Who are the key members and board of directors at Das Drug Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nisha Agarwala | Company Secretary | 09-Dec-2024 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyasha Das
|
Director | 30-Oct-2023 | Current |
|
Pintu Das
|
Director | 30-Oct-2023 | Current |
|
Baisakhi Das
|
Director | 30-Oct-2023 | Current |
Financial Performance of Das Drug Centre.
Enhance accessibility to Das Drug Centre's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Das Drug Centre?
Unlock access to Das Drug Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tresbien Biosynth Private LimitedPiyasha Das is a mutual person
-
Pp & B Mart Private LimitedPiyasha Das and Baisakhi Das are mutual person
-
Prisa Bioformulations Llp
Baisakhi Das is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Das Drug Centre?
Unlock and access historical data on people associated with Das Drug Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Das Drug Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Das Drug Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.